Model G Protein-coupled Receptors Research Articles

Analysis of Lipid GPCR Molecular Interactions by Proximity Labeling.

G-protein-coupled receptors (GPCRs) are hepta-helical transmembrane proteins that mediate various intracellular signaling events in response to their specific ligands including many lipid mediators. Although analyses of GPCR molecular interactions are pivotal to understanding diverse intracellular signaling events, affinity purification of interacting proteins by a conventional co-immunoprecipitation method is challenging due to the hydrophobic nature of GPCRs and their dynamic molecular interactions. Proximity labeling catalyzed by a TurboID system is a powerful technique for defining the molecular interactions of target proteins in living cells. TurboID and miniTurbo (a modified version of TurboID) are engineered biotin ligases that biotinylate neighboring proteins in a promiscuous manner. When fused with a target protein and expressed in living cells, TurboID or miniTurbo mediates the biotin labeling of the proteins with close proximity to the target protein, allowing efficient purification of the biotinylated proteins followed by a shot-gun proteomic analysis. In this chapter, we describe a step-by-step protocol for the labeling of GPCR neighboring proteins by TurboID or miniTurbo, purification of the biotin-labeled proteins, and subsequent sample preparation for proteomic analysis. We utilized S1PR1 as a model GPCR, a receptor for a bioactive lipid molecule sphingosine 1-phosphate (S1P) that plays various roles in physiological and pathological conditions. This analysis pipeline enables the mapping of interacting proteins of lipid GPCRs in living cells.

Protein-Protein Docking Approach to GPCR Oligomerization.

G-protein-coupled receptors (GPCRs), the largest family of human membrane proteins, play a crucial role in cellular control and are the target of approximately one-third of all drugs on the market. Targeting these complexes with selectivity or formulating small molecules capable of modulating receptor-receptor interactions could potentially offer novel avenues for drug discovery, fostering the development of more refined and safer pharmacotherapies. Due to the lack of experimentally derived X-ray crystallography spectra of GPCR oligomers, there is growing evidence supporting the development of new in silico approaches for predicting GPCR self-assembling structures. The significance of GPCR oligomerization, the challenges in modeling these structures, and the potential of protein-protein docking algorithms to address these challenges are discussed. The study also underscores the use of various software solutions for modeling GPCR oligomeric structures and presents practical cases where these techniques have been successfully applied.

Genetic code expansion to enable site-specific bioorthogonal labeling of functional G protein-coupled receptors in live cells.

For use in site-specific bioorthogonal labeling of expressed G protein-coupled receptors (GPCRs) in live cells, we developed a luciferase-based reporter assay. The assay was used to compare amber codon suppression efficiency, receptor functionality, and efficiency of different bioorthogonal labeling chemistries. We used the assay system to compare side-by-side the efficiency of incorporation of three different noncanonical amino acids [4-azido-l-phenylalanine (azF), cyclopropene-l-lysine (CpK), and trans-cyclooct-2-en-l-lysine (TCOK)] at three different sites on a GPCR using three different genetic code expansion plasmid systems. As a model GPCR, we engineered an epitope-tagged C-C chemokine receptor 5 (CCR5)-RLuc3 fusion for expression in HEK293T cells. Satisfactory incorporation of azF, CpK, and TCOK into heterologously expressed CCR5 was achieved. We also carried out cell-based calcium mobilization assays to measure the function of the engineered CCR5, and in the same cells, we performed bioorthogonal labeling of the engineered mutants using heterobivalent compounds containing bioorthogonal tethering groups linked to either a small-molecule fluorophore or a peptide. Favorable reaction kinetics of tetrazine-containing compounds with CCR5 harboring TCOK was observed. However, bioorthogonal labeling in live cells of CCR5 harboring CpK with tetrazine-containing compounds using the inverse electron demand Diels-Alder ligation was overall slightly more efficient than other reactions tested.

Physiological changes in bilayer thickness induced by cholesterol control GPCR rhodopsin function

We monitored the effect on function of the G-protein-coupled receptor (GPCR) rhodopsin from small, stepwise changes in bilayer thickness induced by cholesterol. Over a range of phosphatidylcholine bilayers with hydrophobic thickness from ≈21 Å to 38 Å, the metarhodopsin-I (MI)/metarhodopsin-II (MII) equilibrium was monitored with UV-visible spectroscopy while ordering of hydrocarbon chains was probed by 2H-NMR. Addition of cholesterol shifted equilibrium toward MII for bilayers thinner than the average length of hydrophobic transmembrane helices (27 Å) and to MI for thicker bilayers, while small bilayer thickness changes within the range of the protein hydrophobic thickness drastically up- or downregulated MII formation. The cholesterol-induced shifts toward MII for thinner membranes correlated with the cholesterol-induced increase of bilayer hydrophobic thickness measured by NMR, consistent with continuum elastic modeling. The energetic penalty of adding cholesterol to thick bilayers caused rhodopsin oligomerization and a shift toward MI. In membranes of physiological thickness, changes in bilayer mechanical properties induced by cholesterol potentiated the interplay between bilayer and protein thickness resulting in large swings of the MI-MII equilibrium. In membrane containing cholesterol, elastic deformations near the protein are a dominant energetic contribution to the functional equilibrium of the model GPCR rhodopsin.

Novel Insights into Regulation of GPCR Signaling by GRKs and β‐arrestins

G protein‐coupled receptor (GPCR) signaling is tightly regulated by GPCR kinases (GRKs) and β‐arrestins 1 & 2 (βarr1/2). Following agonist stimulation, GRKs and βarr1/2 are important for returning cells to their physiological resting states by acting in tandem to promote receptor desensitization by reducing the ability of receptors to couple with G proteins and by targeting active GPCRs for endocytosis. In addition, GRKs and arrestins are also known to instigate non‐canonical signaling by scaffolding and activating various effector molecules. Although these functions of βarr1/2 are generalizable to all GPCRs, they can diverge dependent upon the ligand activating the same GPCR and the dominant function can vary between GPCRs. Although inherent properties of the GPCR likely specify these discrete functions, the determinants remain poorly understood. To address this, we are using the chemokine receptor CXCR5 as a model GPCR. CXCR5, and its endogenous ligand, CXCL13, have been linked to diseases ranging from cancer, chronic inflammation, and cardiovascular disease, among others, and yet very little is known about the regulation of CXCR5 signaling. To investigate this, we used CRISPR/Cas9 gene edited βarr1/2 knockout and matched parental HEK293 cells in bioluminescence resonance energy transfer (BRET), receptor trafficking, and signaling assays. Our data show a dose‐dependent increase in the BRET response following CXCL13 stimulation between βarr1/2‐GFP and CXCR5‐Rluc8, suggesting that βarr1/2 is recruited to activated CXCR5 at the plasma membrane. A selective inhibitor of GRK2/3, but not a non‐selective PKC inhibitor, reduced βarr1/2 recruitment to CXCR5 following CXCL13 stimulation. Mutation of potential phosphorylation sites within the carboxy‐terminus of CXCR5 did not impact CXCL13‐stimulated endocytosis, although βarr1/2 recruitment was impaired. Remarkably, CXCL13‐stimulated CXCR5 endocytosis was not impacted in βarr1/2 knockout HEK293 cells, while CXCL13‐stimulated ERK‐1/2 phosphorylation was reduced compared to parental HEK293 cells. Based on these data we hypothesize that CXCR5 signaling is regulated through a complex process that involves GRKs andβ‐arrestins via conventional and non‐conventional mechanisms.To explore this further, in future experiments we will identify the receptor determinants mediating GRK‐phosphorylation and βarr1/2 recruitment to CXCR5 and their contributions to desensitization, endocytosis, and signaling. Overall, we expect to learn how receptor phosphorylation contributes to the divergent functions of βarr1/2 via CXCR5. This research will help illuminate novel mechanisms governing GPCR regulation by GRKs and arrestins, which may translate into better therapeutics for diseases involving GPCR signaling.

Trafficking-defective mutant PROKR2 cycles between endoplasmic reticulum and Golgi to attenuate endoplasmic reticulum stress

G protein-coupled receptors (GPCRs) play crucial roles in numerous physiological and pathological processes. Mutations in GPCRs that result in loss of function or alterations in signaling can lead to inherited or acquired diseases. Herein, studying prokineticin receptor 2 (PROKR2), we initially identify distinct interactomes for wild-type (WT) versus a mutant (P290S) PROKR2 that causes hypogonadotropic hypogonadism. We then find that both the WT and mutant PROKR2 are targeted for endoplasmic reticulum (ER)-associated degradation, but the mutant is degraded to a greater extent. Further analysis revealed that both forms can also leave the ER to reach the Golgi. However, whereas most of the WT is further transported to the cell surface, most of the mutant is retrieved to the ER. Thus, the post-ER itinerary plays an important role in distinguishing the ultimate fate of the WT versus the mutant. We have further discovered that this post-ER itinerary reduces ER stress induced by the mutant PROKR2. Moreover, we extend the core findings to another model GPCR. Our findings advance the understanding of disease pathogenesis induced by a mutation at a key residue that is conserved across many GPCRs and thus contributes to a fundamental understanding of the diverse mechanisms used by cellular quality control to accommodate misfolded proteins.

Homo-oligomerization of the human adenosine A2A receptor is driven by the intrinsically disordered C-terminus.

G protein-coupled receptors (GPCRs) have long been shown to exist as oligomers with functional properties distinct from those of the monomeric counterparts, but the driving factors of oligomerization remain relatively unexplored. Herein, we focus on the human adenosine A2A receptor (A2AR), a model GPCR that forms oligomers both in vitro and in vivo. Combining experimental and computational approaches, we discover that the intrinsically disordered C-terminus of A2AR drives receptor homo-oligomerization. The formation of A2AR oligomers declines progressively with the shortening of the C-terminus. Multiple interaction types are responsible for A2AR oligomerization, including disulfide linkages, hydrogen bonds, electrostatic interactions, and hydrophobic interactions. These interactions are enhanced by depletion interactions, giving rise to a tunable network of bonds that allow A2AR oligomers to adopt multiple interfaces. This study uncovers the disordered C-terminus as a prominent driving factor for the oligomerization of a GPCR, offering important insight into the effect of C-terminus modification on receptor oligomerization of A2AR and other GPCRs reconstituted in vitro for biophysical studies.

Coevolution underlies GPCR-G protein selectivity and functionality

G protein-coupled receptors (GPCRs) regulate diverse physiological events, which makes them as the major targets for many approved drugs. G proteins are downstream molecules that receive signals from GPCRs and trigger cell responses. The GPCR-G protein selectivity mechanism on how they properly and timely interact is still unclear. Here, we analyzed model GPCRs (i.e. HTR, DAR) and Gα proteins with a coevolutionary tool, statistical coupling analysis. The results suggested that 5-hydroxytryptamine receptors and dopamine receptors have common conserved and coevolved residues. The Gα protein also have conserved and coevolved residues. These coevolved residues were implicated in the molecular functions of the analyzed proteins. We also found specific coevolving pairs related to the selectivity between GPCR and G protein were identified. We propose that these results would contribute to better understandings of not only the functional residues of GPCRs and Gα proteins but also GPCR-G protein selectivity mechanisms.

Modulation of GPCR Function by Membrane Lipids and Water

G‐protein‐coupled receptors (GPCRs) are integral membrane proteins that regulate a wide range of normal and disease‐related physiological processes. Our understanding of the role of soft matter such as membrane lipids and cellular water on activation and regulation of the GPCR function remains incomplete. In the standard biochemical model, GPCRs behave as primarily agonist dependent bimodal switches, with little influence of the surrounding medium. However, using the visual receptor rhodopsin as a model GPCR, we show that water drives rhodopsin to a partially disordered, solvent‐swollen conformational ensemble upon light absorption, rendering the standard model obsolete [1], [2]. We placed rhodopsin under varying degrees of osmotic stress using polyethylene glycol solutes and investigated the activation equilibrium response using UV‐Visible spectroscopy. Our results show a flood of ~ 80 water molecules into the rhodopsin interior during photoactivation, a result supported by atomistic molecular dynamics simulations [3]. Furthermore, the osmolyte effects on rhodopsin activation are size dependent: large osmolytes back shift the equilibrium to inactive metarhodopsin‐I (MI), while small osmolytes forward‐shift the equilibrium to active metarhodopsin‐II (MII). We attribute these size effects to varying degrees of osmolyte penetration into the rhodopsin core. Large polymers behave similarly to ideal osmolytes and dehydrate rhodopsin, while smaller polymers wriggle into the rhodopsin interior and stabilize the open MII conformation of rhodopsin. Besides osmotic pressure, the application of hydrostatic pressure also back shifts the metarhodopsin equilibrium but for fundamentally different reasons. Integrating the two force‐based methods together with neutron scattering experiments indicates that the active state of rhodopsin is more hydrated yet simultaneously more structurally collapsed [4]. At the same time, the active GPCR undergoes dynamic volume fluctuations and solvent coupling, which give rise to greater thermal volume. Our results necessitate a new understanding of GPCR activation in which the surrounding soft matter is paramount in governing conformational energy landscapes.Support or Funding InformationNSF (MCB 11817862 and CHE 1904125) and US NIH (EY012049 and EY02604)

Facio‐genital dysplasia 5 (FGD5) regulates G‐protein coupled receptors (GPCRs) signaling to phosphatidylinositol 3 kinase (PI3K) pathway

IntroductionDrugs targeting the VEGF‐pathway have been approved to treat various cancers. However, tumors become resistant to this therapy due to the recruitment of alternative growth factors, acting via cognate endothelial cells (EC) receptor tyrosine kinases (RTK) or g‐protein coupled receptors (GPCR), to cue neo‐angiogenesis. Facio‐genital dysplasia 5 (FGD5) regulates vascular endothelial growth factor (VEGF)‐mediated angiogenesis, and VEGF receptor‐2 trafficking at the endosome. However, the role of FGD5 to regulate other pro‐angiogenic signaling pathways that co‐operate with VEGF has not been explored. Here, we identify a novel role of FGD5 to control G protein‐coupled receptor (GPCR) signaling.MethodsHuman umbilical vein endothelial cells (HUVEC) were mounted on microcarrier beads, suspended in fibrin gels, then co‐cultured with freshly harvested patient‐derived renal cell carcinoma (PD‐RCC) samples. The effect of FGD5 loss on sprouting angiogenesis was evaluated using RNAi against FGD5 in HUVEC. Stromal cell derived factor (SDF)‐1 was used as a model GPCR ligand to study the role of FGD5 in endothelial angiogenesis and PI3K signaling. Further, FDG5 domain‐deletant mutants were transiently overexpressed to rescue the effect of FGD5 knockdown on endothelial PI3K signaling. Western blot and confocal imaging were performed to readout the role of FGD5 in the GPCR/PI3K signaling pathway.ResultsLoss of FGD5 in HUVEC decreased sprouting angiogenesis stimulated by growth factors released from PD‐RCCs. The defect in angiogenesis was accompanied by downregulation of the expression of endothelial tip cell specific marker genes. Knockdown of endothelial FGD5 abolished the SDF‐1 angiogenic effect and SDF‐1 signaling to PI3K‐β and Akt. Inhibition of Rac1, a Rho GTP‐binding protein required for PI3K‐β activity, recapitulated the signaling defects of FGD5 deficiency, suggesting that FGD5 may control PI3K‐β activity through Rac1‐GTP. Overexpression of Dbl (Rho guanine nucleotide exchange factor) domain‐deleted FGD5 (FGD5ΔDbl) reduced SDF‐1‐stimulated Akt phosphorylation, and failed to rescue defective PI3K signalling in FGD5‐deficient cells, indicating that the Dbl domain of FGD5 regulates the activity of PI3K‐β. PI3K‐β and phosphorylated Akt localized to early endosomes after SDF‐1 stimulation, but loss of FGD5 decreased endosomal phosphorylated‐Akt. Failure of Akt activation at PI3K‐β‐positive endosomes suggests a defect in PI3K‐β activity after FGD5 loss.ConclusionsWe identify a novel role of FGD5 to regulate GPCR signaling to PI3K‐β. FGD5 acts at an endosomal convergence node regulating RTK and GPCR angiogenic pathways that may serve as a target for anti‐angiogenic therapy.Support or Funding InformationUniversity of Alberta Doctoral Recruitment Scholarship, Translational Medicine Research Award, Alberta Graduate Excellence Scholarship, Canadian Cancer Society, Division of Nephrology

G-Protein-Coupled Receptors are Solvent-Swollen in the Functionally Active State

G-protein-coupled receptors (GPCRs) are transmembrane receptors that play critical roles in a number of physiological signaling processes. In the standard biochemical model, GPCRs behave as primarily agonist-dependent bimodal switches, with little influence of the surrounding medium. However, using the visual receptor rhodopsin as a model GPCR, we show that water drives rhodopsin to a partially disordered, solvent-swollen conformational ensemble upon light absorption, rendering the standard model obsolete. We placed rhodopsin under varying degrees of osmotic stress using polyethylene glycol solutes and investigated the activation equilibrium response using UV-visible spectroscopy. Our results show a flood of ∼80 water molecules into the rhodopsin interior during photoactivation, a result supported by atomistic MD simulations [1]. Furthermore, the osmolyte effects on rhodopsin activation are size-dependent: large osmolytes back shift the equilibrium to inactive metarhodopsin-I (MI), while small osmolytes forward-shift the equilibrium to active metarhodopsin-II (MII). We attribute these size effects to varying degrees of osmolyte penetration into the rhodopsin core. Large polymers behave similarly to ideal osmolytes and dehydrate rhodopsin, while smaller polymers wriggle into the rhodopsin interior and stabilize the open MII conformation of rhodopsin. Besides osmotic pressure, the application of hydrostatic pressure also back shifts the metarhodopsin equilibrium but for fundamentally different reasons. Integrating the two force-based methods together with neutron scattering experiments [2] indicates that the active state of rhodopsin is more hydrated yet more locally collapsed. At the same time, the active GPCR undergoes volume fluctuations and solvent coupling, which give rise to greater thermal volume. The combined force-based results necessitate a new understanding of GPCR activation in which the surrounding soft matter is paramount in governing conformational energy landscapes. [1] N. Leioatts et al. (2014) Biochemistry 53, 376−385. [2] S.M.D.C. Perera et al. (2018) J. Phys. Chem. Lett.9, 7064−7071.

Hydration Modulates G‐Protein‐Coupled Receptor Signaling

Rhodopsin is the G‐protein‐coupled receptor (GPCR) responsible for scotopic vision in the retina. Up to this point, the role of water in the activation of GPCRs has remained largely unknown. Recently, however, nanosecond molecular dynamics simulations have revealed an influx of bulk water into rhodopsin during activation [1]. Utilizing rhodopsin as a model GPCR, we tested the hypothesis that rhodopsin activation is hydration mediated using osmotic stress techniques. We subjected rhodopsin within its native lipid membranes to varying osmotic pressures induced by different‐sized polyethylene glycol polymers. UV‐Visible spectroscopy of the photoactivated rhodopsin system reveals the fraction of protein in the active metarhodopsin‐II (MII) conformation, the receptor state capable of activating the G‐protein. We discovered high‐molecular weight osmolytes uniformly favored the closed, inactive metarhodopsin‐I conformation by dehydration of the protein interior. By contrast, small osmolytes penetrated into the transducin binding cleft and stabilized the active MII conformation until a quantifiable saturation point. A universal osmotic response occurred in the limit of increasing osmolyte size and maximal polymer exclusion from rhodopsin. By measuring the thermodynamic dependence of the metarhodopsin equilibrium on osmotic pressure, we determined that rhodopsin activation is coupled to a bulk influx of 80–100 water molecules into the protein core with a substantial increase in compressibility. We propose a new model for the functional role of water in GPCR signal transduction, in which a wet‐dry cycling mechanism amplifies the activation of G‐proteins. Our results necessitate a new understanding of GPCR activation, in which the influx of water plays a critical role in establishing the active receptor conformation.Support or Funding InformationThis work was supported by the NIH (EY026041 and EY012049) and the NSF (MCB 1817862).This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Homology-based Modeling of Rhodopsin-like Family Members in the Inactive State: Structural Analysis and Deduction of Tips for Modeling and Optimization.

Modeling G-Protein Coupled Receptors (GPCRs) is an emergent field of research, since utility of high-quality models in receptor structure-based strategies might facilitate the discovery of interesting drug candidates. The findings from a quantitative analysis of eighteen resolved structures of rhodopsin family "A" receptors crystallized with antagonists and 153 pairs of structures are described. A strategy termed endeca-amino acids fragmentation was used to analyze the structures models aiming to detect the relationship between sequence identity and Root Mean Square Deviation (RMSD) at each trans-membrane-domain. Moreover, we have applied the leave-one-out strategy to study the shiftiness likelihood of the helices. The type of correlation between sequence identity and RMSD was studied using the aforementioned set receptors as representatives of membrane proteins and 98 serine proteases with 4753 pairs of structures as representatives of globular proteins. Data analysis using fragmentation strategy revealed that there is some extent of correlation between sequence identity and global RMSD of 11AA width windows. However, spatial conservation is not always close to the endoplasmic side as was reported before. A comparative study with globular proteins shows that GPCRs have higher standard deviation and higher slope in the graph with correlation between sequence identity and RMSD. The extracted information disclosed in this paper could be incorporated in the modeling protocols while using technique for model optimization and refinement.

Construction of Structural Mimetics of the Thyrotropin Receptor Intracellular Domain

The signaling of a G protein-coupled receptor (GPCR) is dictated by the complementary responsiveness of interacting intracellular effectors such as G proteins. Many GPCRs are known to couple to more than one G protein subtype and induce a multitude of signaling pathways, although the in vivo relevance of particular pathways is mostly unrecognized. Dissecting GPCR signaling in terms of the pathways that are activated will boost our understanding of the molecular fundamentals of hormone action. The structural determinants governing the selectivity of GPCR/G protein coupling, however, remain obscure. Here, we describe the design of soluble GPCR mimetics to study the details of the interplay between G-proteins and activators. We constructed functional mimetics of the intracellular domain of a model GPCR, the thyrotropin receptor. We based the construction on a unique scaffold, 6-Helix, an artificial protein that was derived from the elements of the trimer-of-hairpins structure of HIV gp41 and represents a bundle of six α-helices. The 6-Helix scaffold, which endowed the substituted thyrotropin receptor intracellular domain elements with spatial constraints analogous to those found in native receptors, enabled the reconstitution of a microdomain that consists of intracellular loops 2 and 3, and is capable of binding and activating Gα-(s). The 6-Helix-based mimetics could be used as a platform to study the molecular basis of GPCR/G protein recognition. Such knowledge could help investigators develop novel therapeutic strategies for GPCR-related disorders by targeting the GPCR/G protein interfaces and counteracting cellular dysfunctions via focused tuning of GPCR signaling.

Uncovering and Reprogramming G Protein Coupled Receptor Signaling

G-protein-coupled receptors (GPCRs) constitute one of the largest classes of signaling membrane receptors and drug targets. GPCRs display a large diversity of constitutive activities and responses to extracellular stimuli defining their complex physiologies. Yet, how receptor sequences and structures encode these allosteric properties remains poorly understood and difficult to study in absence of high-resolution structural information for many GPCRs. To address this problem, my laboratory has developed computational techniques to model GPCRs, predict ligand-bound GPCR conformations from a large diversity of structural homologs and design membrane receptors with novel functions. Using these methods, we have rationally engineered structurally-uncharacterized GPCRs with novel ligand binding selectivities, allosteric regulation properties and self-association propensities. I will also discuss how, during the course of these studies, we uncovered novel molecular determinants of membrane protein functions.

ENDOSOMAL GENERATION OF cAMP in GPCR SIGNALING

It has been widely assumed that the production of the ubiquitous second messenger cAMP mediated by cell surface G protein-coupled receptors (GPCR) and its termination take place exclusively at the plasma membrane. Recent studies are revealing that diverse GPCRs do not always follow this conventional paradigm. In the new model GPCRs mediate G protein signaling not only from the plasma membrane, but also from endosomal membranes. This model proposes that following ligand binding and activation, cell surface GPCRs internalize and redistribute into early endosomes where trimeric G proteins signaling can be maintained for an extended period of time. This presentation will discuss the molecular and cellular mechanistic subtleties as well as the physiological consequences and potential medical applications of this unexpected process, which is drastically changing how we think about GPCR signaling and regulation, and how we study drugs that target this receptor family.

The GGA Family Proteins Modulate the Cell Surface Transport of α2B‐Adrenergic Receptor through Specific Interactions

Molecular mechanisms governing the cell surface transport of G‐protein‐coupled receptors (GPCRs) remain poorly elucidated. Here, we used α2B‐adrenergic receptor (α2B‐AR) as a model GPCR to determine the role of three Golgi‐localized, γ‐adaptin ear domain homology, ADP ribosylation factor‐binding proteins (GGAs), one family of adaptor proteins for clathrin‐coated vesicles involved in the trans‐Golgi network (TGN)‐to‐endosome transport. It has been well described that the function of GGAs is tightly controlled by interactions via their VHS domain with the acidic LL motifs presented in the C‐terminus of cargo molecules. We found that shRNA‐mediated depletion of individual GGAs strongly arrested α2B‐AR in the Golgi/TGN and significantly reduced the cell surface expression and signaling of the receptor. We further demonstrated that GGAs physically associated with α2B‐AR through specific domains. The GGA‐binding domains were mapped to the C‐terminal regions in the third intracellular loop of α2B‐AR, whereas α2B‐AR‐binding domains were identified to the hinge domain of GGA1, the GAE domain of GGA2 and the VHS domain of GGA3. These studies reveal a novel function of the GGA family proteins in the TGN‐to‐plasma membrane transport of α2B‐AR which is likely mediated through a non‐conventional mechanism. These data also suggest that the GGA adaptor proteins are important mediators of GPCR cell surface targeting.

Novobiocin and peptide analogs of α-factor are positive allosteric modulators of the yeast G protein-coupled receptor Ste2p

G protein-coupled receptors (GPCRs) are the target of many drugs prescribed for human medicine and are therefore the subject of intense study. It has been recognized that compounds called allosteric modulators can regulate GPCR activity by binding to the receptor at sites distinct from, or overlapping with, that occupied by the orthosteric ligand. The purpose of this study was to investigate the nature of the interaction between putative allosteric modulators and Ste2p, a model GPCR expressed in the yeast Saccharomyces cerevisiae that binds the tridecapeptide mating pheromone α-factor. Biological assays demonstrated that an eleven amino acid α-factor analog and the antibiotic novobiocin were positive allosteric modulators of Ste2p. Both compounds enhanced the biological activity of α-factor, but did not compete with α-factor binding to Ste2p. To determine if novobiocin and the 11-mer shared a common allosteric binding site, a biologically-active analog of the 11-mer peptide ([Bio-DOPA]11-mer) was chemically cross-linked to Ste2p in the presence and absence of novobiocin. Immunoblots probing for the Ste2p–[Bio-DOPA]11-mer complex revealed that novobiocin markedly decreased cross-linking of the [Bio-DOPA]11-mer to the receptor, but cross-linking of the α-factor analog [Bio-DOPA]13-mer, which interacts with the orthosteric binding site of the receptor, was minimally altered. This finding suggests that both novobiocin and [Bio-DOPA]11-mer compete for an allosteric binding site on the receptor. These results indicate that Ste2p may provide an excellent model system for studying allostery in a GPCR.

Membrane-Lipid Mediated Rhodopsin Signaling Involves an Ensemble of Conformational Substates

G-protein-coupled receptors (GPCRs) constitute about 50% of the known drug targets. Using rhodopsin as a model GPCR, we study the role of membrane lipids in the rhodopsin activation. Absorption of light by rhodopsin leads to a series of conformational changes that establishes an equilibrium between inactive Meta-I and an ensemble of activated Meta-II states [1,2]. Using UV-visible and FTIR spectroscopy, we show that the distribution of late conformational substates during rhodopsin activation is lipid-mediated as explained by an ensemble activation mechanism (EAM). Lipid bilayer composition (head groups and acyl chain lengths) and membrane protein-lipid interaction govern the EAM through biasing conformational substates. Rhodopsin reconstituted in DOPC backshifts the equilibrium to the Meta-IIa substate, whereas mixed-chain POPC membranes favor the inactive Meta-I state [3]. The wavenumber-dependent analysis of the FTIR-difference spectra yields a distribution of pKa and alkaline endpoint values, consistent with an ensemble of substates for each lipid bilayer-rhodopsin system. A phenomenological Henderson-Hasselbalch function was fitted to the pH titration curves to derive thermodynamic parameters from the spectral analysis. Our thermodynamic studies show that activation of rhodopsin is accompanied by an entropy gain compensating the unfavorable enthalpy increase, analogous to protein unfolding reactions. The results from the EAM analysis are in agreement with the flexible surface model (FSM), which describes elastic coupling of the membrane lipids to integral membrane proteins through a balance of curvature and hydrophobic forces in lipid-protein interactions [4]. Our study also provides insight into the thermodynamic parameters that govern rhodopsin-like GPCR activation in native membrane lipid environments. [1] A.V. Struts et al. (2011) PNAS 108, 8263-8268. [2] A.V. Struts et al. (2014) Meth. Mol. Biol. (in press). [3] E. Zaitseva et al. (2010) JACS 132, 4815-4821. [4] M.F. Brown (2012) Biochemistry 51, 9782-9795.

Computational approaches for modeling GPCR dimerization.

Growing experimental evidences suggest that dimerization and oligomerization are important for G Protein- Coupled Receptors (GPCRs) function. The detailed structural information of dimeric/oligomeric GPCRs would be very important to understand their function. Although it is encouraging that recently several experimental GPCR structures in oligomeric forms have appeared, experimental determination of GPCR structures in oligomeric forms is still a big challenge, especially in mimicking the membrane environment. Therefore, development of computational approaches to predict dimerization of GPCRs will be highly valuable. In this review, we summarize computational approaches that have been developed and used for modeling of GPCR dimerization. In addition, we introduce a novel two-dimensional Brownian Dynamics based protein docking approach, which we have recently adapted, for GPCR dimer prediction.